In the preceding three months, 12 analysts have released ratings for DexCom (NASDAQ:DXCM), presenting a wide array of ...
Out of the diabetes patients surveyed, 46% said they would feel more in control of their disease in everyday life if they could identify trends before they turn into problems.
Senseonics' Eversense 365 drives 72% Q4 growth as company reclaims U.S. commercialization and targets 65-76% revenue increase in 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results